Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection
Authors:
- D. NathwaniDND. Nathwani
- M.H. WilcoxMWM.H. Wilcox
- J. StephensJSJ. Stephens
- A. ShelbayaASA. Shelbaya
- S. HaiderSHS. Haider
- 1 May 2012
- journal article
- review article
- Published by Elsevier in Journal of Hospital Infection
- Vol. 81 (1) , 1-14
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
- Bayer
This publication has 56 references indexed in Scilit:
- The economic burden of Clostridium difficileClinical Microbiology and Infection, 2012
- The Changing Epidemiology of Clostridium difficile InfectionsClinical Microbiology Reviews, 2010
- Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel diseaseEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Risk Factors for and Estimated Incidence of Community-associatedClostridium difficileInfection, North Carolina, USA1Emerging Infectious Diseases, 2010
- Hospitalizations and Deaths Associated withClostridium difficileInfection, Finland, 1996–20041Emerging Infectious Diseases, 2009
- An outbreak of Clostridium difficile-associated disease (CDAD) in a German university hospitalEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Emergence ofClostridium difficileInfection Due to a New Hypervirulent Strain, Polymerase Chain Reaction Ribotype 078Clinical Infectious Diseases, 2008
- Epidemiology of Clostridium difficile-associated disease at University Hospital Basel including molecular characterisation of the isolates 2006–2007European Journal of Clinical Microbiology & Infectious Diseases, 2008
- Clinical Severity of Clostridium difficile PCR Ribotype 027: A Case-Case StudyPLOS ONE, 2008
- Financial burden of hospital-acquired Clostridium difficile infectionJournal of Hospital Infection, 1996